Evidence map›Paper›PMID 36496400›Full record

ArticleBMC nephrology2022

Significance of thyroid dysfunction in the patients with primary membranous nephropathy.

Qiu-Hua Gu, Xin Cao, Xiao-Ming Mao, Jun-Ya Jia, Tie-Kun Yan

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Qiu-Hua Gu *Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Xin Cao *Department of Nephrology, Tianjin Medical University General Hospital Airport Hospital, Tianjin, 300308, China.
Xiao-Ming MaoDepartment of Nephrology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Jun-Ya JiaDepartment of Nephrology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Tie-Kun YanDepartment of Nephrology, Tianjin Medical University General Hospital, Tianjin, 300052, China. tjtiekun@163.com.
Tianjin Medical University General Hospital · CN

Funding

National Natural Science Foundation of China 82000669Tianjin Key Medical Discipline Construction Project TJYXZDXY-071C
6 · The paper itself

Abstract

backgroundThyroid dysfunction is common in patients with nephrotic syndrome, especially patients with primary membranous nephropathy (pMN). In view of both MN and thyroid dysfunction are associated with autoimmunity, the current study aimed to elucidate the significance of thyroid dysfunction in patients with pMN.

methodsFour hundred and twenty patients with biopsy-proven pMN from 2018-2021 were retrospectively enrolled. Clinical and pathological parameters, and treatment response of patients with and without thyroid dysfunction were analyzed.

resultsNinety-one (21.7%) patients with pMN suffered from thyroid dysfunction, among which subclinical hypothyroidism (52.7%) was the main disorder. Compared to patients with normal thyroid function, patients with thyroid dysfunction presented with a higher level of proteinuria, a lower level of serum albumin, a higher level of serum creatinine and more severe tubulointerstitial injury at the time of biopsy. But the positive rate and level of circulating anti-phospholipase A2 receptor (PLA2R) antibody were comparable between these two groups. Though following the similar treatment, the percentage of no response to treatment were significantly higher in the patients with thyroid dysfunction (38.6 vs. 20.0%, P = 0.003). Similar to the urinary protein and the positivity of anti-PLA2R antibody, multivariate COX analysis showed thyroid dysfunction was also identified as an independent risk factor for the failure to remission (HR = 1.91, 95%CI, 1.07-3.40, P = 0.029).

conclusionIn conclusion, thyroid dysfunction is common in the patients with pMN and might predict a severe clinical manifestation and a poor clinical outcome, which indicated that the thyroid dysfunction might be involved in the disease progression of pMN.

Indexed as

Glomerulonephritis, MembranousThyroid GlandAutoantibodiesHumansProteinuriaReceptors, Phospholipase A2Retrospective StudiesAutoantibodiesReceptors, Phospholipase A2Anti-PLA2R antibodyMembranous nephropathyThyroid dysfunction

Identifiers

PMID36496400
PMCPMC9737752
OpenAlexW4311669634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.